These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32716637)

  • 41. LncRNA CASC15 promotes migration and invasion in prostate cancer via targeting miR-200a-3p.
    Zhang C; Wang GX; Fu B; Zhou XC; Li Y; Li YY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7215. PubMed ID: 32706053
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Potvin N; Hicks M; Kronk R
    J Altern Complement Med; 2021 Dec; 27(12):e1156-e1158. PubMed ID: 33902291
    [No Abstract]   [Full Text] [Related]  

  • 43. Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p.
    Wang Q; Han J; Xu P; Jian X; Huang X; Liu D
    Cancer Manag Res; 2021; 13():1831-1841. PubMed ID: 33654431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retraction.
    J Cell Physiol; 2022 Mar; 237(3):1995. PubMed ID: 34287864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S62. PubMed ID: 34191291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1():S98. PubMed ID: 34191361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retraction.
    J Cell Physiol; 2022 Mar; 237(3):1996. PubMed ID: 34287879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Retracted] LINC01638 silencing inhibits cancer cell proliferation in colorectal adenocarcinoma through interaction with RUNX2.
    Zhuo W; Hu D; Chen X; Zhang T
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33537797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
    Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3397. PubMed ID: 34002806
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Retracted] lncRNA XIST promotes the progression of laryngeal squamous cell carcinoma by sponging miR‑144 to regulate IRS1 expression.
    Cui CL; Li YN; Cui XY; Wu X
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34676882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Retracted] miR‑506 functions as a tumor suppressor in glioma by targeting STAT3.
    Peng T; Zhou L; Zuo L; Luan Y
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34726249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retraction.
    J Cell Biochem; 2021 May; 122(5):600. PubMed ID: 33786921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer.
    Yu Y; Dong JT; He B; Zou YF; Li XS; Xi CH; Yu Y
    Future Oncol; 2019 Nov; 15(33):3831-3844. PubMed ID: 31664866
    [No Abstract]   [Full Text] [Related]  

  • 54. Expression of Concern: LncRNA MEG3 inhibits proliferation and promotes apoptosis of synovial cells in rats with knee osteoarthritis by regulating PTEN.
    Han K; Wang FR; Yu MQ; Xu B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8622. PubMed ID: 32964944
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retraction.
    J Cell Biochem; 2021 Nov; 122(11):1761. PubMed ID: 34111302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Retracted] miR‑363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
    Ye J; Zhang W; Liu S; Liu Y; Liu K
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34498717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retraction.
    J Cell Biochem; 2021 Nov; 122 Suppl 1(Suppl 1):S132. PubMed ID: 34342912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retraction.
    J Cell Physiol; 2022 Apr; 237(4):2294. PubMed ID: 34873697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA INHBA-AS1 promotes cell growth, migration, and invasion of oral squamous cell carcinoma by sponging miR-143-3p.
    Ma WQ; Chen J; Fang W; Yang XQ; Zhu A; Zhang D; Zhong HL; Yang B; Luo Z
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9240. PubMed ID: 33015761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA SNHG16 promotes proliferation and migration in laryngeal squamous cell carcinoma via the miR-140-5p/NFAT5/Wnt/β-catenin pathway axis.
    Wan L; Gu D; Li P
    Pathol Res Pract; 2022 Jan; 229():153727. PubMed ID: 34911016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.